EU, AstraZeneca Reach Deal To End Vaccine Delivery Dispute

FILE - In this Monday, March 22, 2021 file photo medical staff prepares an AstraZeneca coronavirus vaccine during preparations at the vaccine center in Ebersberg near Munich, Germany. British authorities recommended Wednesday, April 7, that the AstraZeneca COVID-19 vaccine not be given to adults under 30 where possible because of strengthening evidence that the shot may be linked to rare blood clots. The recommendation came as regulators both in the U.K. and the European Union emphasized that the benefits of receiving the vaccine continue to outweigh the risks for most people. (AP Photo/Matthias Schrader, File)

(AP) — The European Union and drugmaker AstraZeneca say they reached a deal to end a damaging legal battle over the slow pace of deliveries of the company’s COVID-19 vaccines. The European Commission said Friday that AstraZeneca made a “firm commitment” to deliver a total of 300 million vaccine doses by March. The commission said it involves the pharmaceutical company providing 135 million doses by the end of this year plus another 65 million doses in the first quarter of 2022. Around 100 million have already been supplied. Brussels says the deliveries would respect an advance purchasing agreement the EU reached with AstraZeneca a year ago.

US Hiring Slows To Just 235,000 Jobs After 2 Strong Months

Previous article

Afghan Women Demand Rights As Taliban Seek Recognition

Next article

You may also like

More in WORLD